Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease.

Abstract:

BACKGROUND:Sleep disorders occur commonly in Parkinson's disease and are often under-recognized and under treated in clinical practice. OBJECTIVES:To determine the quality of sleep in patients with Young onset Parkinson's disease (YOPD) and to note whether there is any difference in quality of sleep from those patients with older onset Parkinson's disease (OOPD). METHODS:One hundred and fifty six patients with Parkinson's disease (YOPD-51, OOPD-105) were clinically examined and quality of sleep was determined using Pittsburgh sleep quality index (PSQI), Parkinson's disease Sleep Scale (PDSS) and Epworth Sleep Scale (ESS). Other scales included Unified Parkinson's Disease Rating Scale -part III (UPDRS-III), Hoehn & Yahr Stage, Mini Mental Status Examination, Hamilton anxiety rating scale and Hamilton depression rating scale. RESULTS:The frequency of insomnia was higher in OOPD (55.2%) as compared to YOPD (27.5%) group (p = 0.001). The frequency of nightmares was lower in YOPD (7.8%) when compared to OOPD (24.8%) group (p = 0.012). The mean hours of actual sleep per night were higher in YOPD patients. Global PSQI score was better in YOPD indicating good overall sleep quality in YOPD patients. The total ESS score was significantly lower in YOPD (p = 0.019). The total PDSS score was significantly better in YOPD patients (p = 0.018). CONCLUSIONS:Patients with YOPD had an overall better quality of sleep with lesser incidence of insomnia, nightmares, daytime sleepiness and restlessness during sleep.

authors

Mahale R,Yadav R,Pal PK

doi

10.1016/j.parkreldis.2015.02.007

subject

Has Abstract

pub_date

2015-05-01 00:00:00

pages

461-4

issue

5

eissn

1353-8020

issn

1873-5126

pii

S1353-8020(15)00062-0

journal_volume

21

pub_type

杂志文章
  • Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease.

    abstract::Current concepts regarding the pathogenesis of Parkinson's disease support a model whereby environmental factors conspire with a permissive genetic background to initiate the disease. The identity of the responsible environmental trigger has remained elusive. There is incontrovertible evidence that aggregation of the ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2014.02.031

    authors: Woulfe JM,Gray MT,Gray DA,Munoz DG,Middeldorp JM

    更新日期:2014-07-01 00:00:00

  • Mind the gaps: What we don't know about cognitive impairment in essential tremor.

    abstract:INTRODUCTION:Although the hallmark feature of essential tremor (ET) is tremor, there is growing appreciation that cognitive impairment also occurs, including increased prevalence of mild cognitive impairment (MCI) and increased prevalence and incidence of dementia. With emerging knowledge of ET-cognitive impairment, co...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2019.02.038

    authors: Louis ED,Joyce JL,Cosentino S

    更新日期:2019-06-01 00:00:00

  • Orthostatic myoclonus after brain tumor radiation: Insights from two lesional cases.

    abstract:INTRODUCTION:Orthostatic myoclonus (OM) is a recognized syndrome of gait unsteadiness accompanied by lower limb myoclonus provoked by the assumption of an upright posture. OM typically affects the elderly and is often associated with neurodegenerative disease. We sought to review the clinical and electrophysiologic cha...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2017.04.015

    authors: Cutsforth-Gregory JK,Hammack JE,Matsumoto JY

    更新日期:2017-08-01 00:00:00

  • Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

    abstract:BACKGROUND:Non-motor symptoms (NMS) are common in Parkinson's disease (PD) and cause significant distress. A high rate of non-declaration of NMS by patients to healthcare providers (HCP) means that many NMS remain untreated. Current understanding of the factors preventing disclosure of NMS to HCPs is limited. The prese...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.04.014

    authors: Hurt CS,Rixon L,Chaudhuri KR,Moss-Morris R,Samuel M,Brown RG

    更新日期:2019-07-01 00:00:00

  • The overlap between Essential tremor and Parkinson disease.

    abstract:INTRODUCTION:Essential tremor (ET) and Parkinson's disease (PD) are common disorders especially in the aging population and can have overlapping features that can make it difficult to differentiate between the two. In addition, a possible overlap from a pathophysiological standpoint has been often advocated in the past...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2017.07.006

    authors: Algarni M,Fasano A

    更新日期:2018-01-01 00:00:00

  • Task-switching abilities in pre-manifest Huntington's disease subjects.

    abstract:INTRODUCTION:Huntington's Disease (HD) cognitive dysfunction occurs before unequivocal motor signs become apparent. The predominant early cognitive abnormal domains may include deficits in psychomotor speed, negative emotion recognition and executive functioning. Our study is aimed to investigate the executive control ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2018.09.007

    authors: Migliore S,D'Aurizio G,Curcio G,Squitieri F

    更新日期:2019-03-01 00:00:00

  • Effects of augmented visual feedback during balance training in Parkinson's disease: a pilot randomized clinical trial.

    abstract:BACKGROUND:Balance training has been demonstrated to improve postural control in patients with Parkinson's disease (PD). The objective of this pilot randomized clinical trial was to investigate whether a balance training program using augmented visual feedback is feasible, safe, and more effective than conventional bal...

    journal_title:Parkinsonism & related disorders

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.parkreldis.2014.09.022

    authors: van den Heuvel MR,Kwakkel G,Beek PJ,Berendse HW,Daffertshofer A,van Wegen EE

    更新日期:2014-12-01 00:00:00

  • Non motor subtypes and Parkinson's disease.

    abstract::Non motor symptoms (NMS) represent a significant burden in Parkinson's disease (PD) with numerous studies highlighting the importance of NMS both in "pre-motor" phase of PD as well as throughout the course of disease. In part this has led the international Parkinson and Movement Disorder Society (IPMDS) task force to ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2015.09.027

    authors: Sauerbier A,Jenner P,Todorova A,Chaudhuri KR

    更新日期:2016-01-01 00:00:00

  • A novel bedside task to tap inhibitory dysfunction and fronto-striatal atrophy in Parkinson's disease.

    abstract:BACKGROUND:Given the heterogeneity of mild cognitive deficits in non-demented Parkinson's disease (PD), sensitive and anatomically specific behavioural measures are crucial when evaluating cognition in this patient group. Inhibitory dysfunction is one such deficit increasingly being recognised in non-demented PD; howev...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2013.04.020

    authors: O'Callaghan C,Naismith SL,Shine JM,Bertoux M,Lewis SJ,Hornberger M

    更新日期:2013-09-01 00:00:00

  • From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease.

    abstract::The MPTP-treated primate has proved to be a highly predictive model of the effects of dopaminergic drugs in the symptomatic treatment of Parkinson's disease (PD) and for the avoidance of motor complications. Using MPTP-treated primates, new dopaminergic therapies have been devised alongside novel treatment strategies ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(09)70829-6

    authors: Jenner P

    更新日期:2009-12-01 00:00:00

  • Quantifying physical activity in early Parkinson disease using a commercial activity monitor.

    abstract:INTRODUCTION:Physical inactivity in Parkinson disease (PD) has an impact on motor and non-motor symptoms of the disease. It is unclear whether this decline in physical activity occurs early in the disease, in addition to any decline due to aging, and whether commercial activity monitors can be used to self-monitor phys...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.08.001

    authors: Pradhan S,Kelly VE

    更新日期:2019-09-01 00:00:00

  • The evolving definition of essential tremor: What are we dealing with?

    abstract:BACKGROUND:Although essential tremor (ET) is commonly encountered in clinical practice, historically, there has been considerable disagreement as how to best define it, and now with a growing sense of its clinical complexity, how to best encapsulate it. Here, I draw attention to five issues of current uncertainty. MET...

    journal_title:Parkinsonism & related disorders

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.parkreldis.2017.07.004

    authors: Louis ED

    更新日期:2018-01-01 00:00:00

  • Health-related quality of life and alternative forms of exercise in Parkinson disease.

    abstract::Parkinson disease (PD) reduces health-related quality of life (HRQoL), but exercise may improve HRQoL. This pilot study compared the effects of Tango, Waltz/Foxtrot, Tai Chi and No Intervention on HRQoL in individuals with PD. Seventy-five persons with PD (Hoehn and Yahr I-III) were assigned to 20 lessons of Tango, Wa...

    journal_title:Parkinsonism & related disorders

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.parkreldis.2009.03.003

    authors: Hackney ME,Earhart GM

    更新日期:2009-11-01 00:00:00

  • Trace amine associated receptor 1 and movement control.

    abstract::The recently discovered trace amine associated receptors (TAARs) represent attractive potential mediators of certain aspects of movement control. The TAAR that is best characterized, TAAR1, is particularly interesting because it can be activated by a variety of monoaminergic compounds including trace amines, amphetami...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2008.04.006

    authors: Sotnikova TD,Zorina OI,Ghisi V,Caron MG,Gainetdinov RR

    更新日期:2008-01-01 00:00:00

  • Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum.

    abstract::Hereditary spastic paraplegia with thin corpus callosum is a rare degenerative disease, which is characterized by a progressive weakness of the lower limbs with a hypoplastic corpus callosum, and is often associated with other symptoms such as mental impairment, amyotrophy, sensory disturbances, dysuria, nystagmus and...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2004.05.003

    authors: Kang SY,Lee MH,Lee SK,Sohn YH

    更新日期:2004-10-01 00:00:00

  • Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease.

    abstract::The present report documents a patient harboring an alpha-synuclein p.A53T variant from a family presenting with autosomal dominant inheritance, including four patients clinically diagnosed with Parkinson's disease (PD) and two with dementia. The alpha-synuclein p.A53T variant is linked to young- or middle-aged onset ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.11.001

    authors: Nishioka K,Hashizume Y,Takanashi M,Daida K,Li Y,Yoshino H,Tambasco N,Prontera P,Hattori Y,Ueda A,Watanabe H,Hattori N

    更新日期:2020-12-01 00:00:00

  • Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation.

    abstract:BACKGROUND/OBJECTIVE:Essential tremor (ET) can diminish functioning and quality of life (QOL) but generic QOL measures may be relatively insensitive to ET and its therapies. We sought to develop an ET-specific measure that might be more sensitive, acceptable to patients, relatively brief, and easily used. DESIGN/METHO...

    journal_title:Parkinsonism & related disorders

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.parkreldis.2005.05.009

    authors: Tröster AI,Pahwa R,Fields JA,Tanner CM,Lyons KE

    更新日期:2005-09-01 00:00:00

  • Apolipoprotein E ε4 genotype and risk of freezing of gait in Parkinson's disease.

    abstract:OBJECTIVE:To investigate the association between Apolipoprotein E (APOE) genotype and freezing of gait (FOG) in Parkinson's disease (PD). METHODS:This cohort study included 339 early PD patients who were divided into APOE ε4-positive (n = 88) and ε4-negative (n = 251) groups. They were followed-up for up to 6 years to...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.10.033

    authors: Kim R,Shin JH,Park S,Kim HJ,Jeon B

    更新日期:2020-12-01 00:00:00

  • Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease.

    abstract::There is evidence that astrocytes and microglia can release agents which might have a protective effect on damaged neurons. However the associations of glia with dopaminergic neurons in Parkinson's disease are not defined. Our studies showed that in post mortem parkinsonian nigra healthy neuronal somata were enveloped...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(99)00022-x

    authors: Knott C,Wilkin GP,Stern G

    更新日期:1999-09-01 00:00:00

  • The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.

    abstract:OBJECTIVES:To determine whether vascular parkinsonism (VaP) patients with visually normal dopamine transporter (DAT) scans have presynaptic dopaminergic depletion. METHODS:We enrolled 23 VaP patients who had parkinsonism, relevant diffuse subcortical white matter hyperintensities (WMH), and visually normal DAT scans, ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.11.002

    authors: Lee YH,Lee S,Chung SJ,Yoo HS,Jung JH,Baik K,Ye BS,Sohn YH,Yun M,Lee PH

    更新日期:2021-01-01 00:00:00

  • Delayed administration of dopaminergic drugs is not associated with prolonged length of stay of hospitalized patients with Parkinson's disease.

    abstract:BACKGROUND:Punctual delivery of dopaminergic medication to Parkinson's disease (PD) patients may be important in optimizing disease control. We tested the hypothesis that prompt delivery of l-dopa medications to emergency hospital inpatients was associated with a decreased length of stay in hospital. METHODS:The study...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.11.004

    authors: Skelly R,Brown L,Fogarty A

    更新日期:2017-02-01 00:00:00

  • Wheeled and standard walkers in Parkinson's disease patients with gait freezing.

    abstract:OBJECTIVES:Compare the efficacy of two walking assistance devices (wheeled walker and standard walker) to unassisted walking for patients with PD and gait freezing. BACKGROUND:Although numerous walking devices are used clinically, their relative effects on freezing and walking speed have never been systematically test...

    journal_title:Parkinsonism & related disorders

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1353-8020(03)00060-9

    authors: Cubo E,Moore CG,Leurgans S,Goetz CG

    更新日期:2003-10-01 00:00:00

  • Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease--a study from Southwest China.

    abstract:BACKGROUND:Non-motor symptom (NMS) differences between male Parkinson's disease (PD) and female PD, and between early-onset PD (EOPD) and late-onset PD (LOPD) in Chinese populations remain largely unknown. METHODS:A total of 522 PD patients from Southwest China were included. Patients were assessed using the Non-Motor...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2013.06.009

    authors: Guo X,Song W,Chen K,Chen X,Zheng Z,Cao B,Huang R,Zhao B,Wu Y,Shang HF

    更新日期:2013-11-01 00:00:00

  • Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.

    abstract:INTRODUCTION:Inconsistent results regarding the association between the components of metabolic syndrome and Parkinson's disease (PD) have been reported. We investigated whether the metabolic syndrome or its components, or serum total cholesterol, predict PD incidence in a prospective cohort study design. METHODS:The ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.07.017

    authors: Sääksjärvi K,Knekt P,Männistö S,Lyytinen J,Heliövaara M

    更新日期:2015-10-01 00:00:00

  • Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype.

    abstract:INTRODUCTION:Mutations in GNAL have been associated with adult-onset cranio-cervical dystonia, but a limited number of cases have been reported so far and the clinical spectrum associated with this gene still needs to be fully characterized. METHODS:We identified an Italian family with adult-onset, dominantly-inherite...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.12.012

    authors: Carecchio M,Panteghini C,Reale C,Barzaghi C,Monti V,Romito L,Sasanelli F,Garavaglia B

    更新日期:2016-02-01 00:00:00

  • Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data.

    abstract:INTRODUCTION:Increasing evidence demonstrates the relevant association between Parkinson's disease (PD) and vascular diseases/risk factors, as well as a worse clinico-pathological progression in those patients with vascular comorbidity. The mechanisms underlying this relationship have not been clarified yet, although t...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.04.004

    authors: Imbriani P,D'Angelo V,Platania P,Di Lazzaro G,Scalise S,Salimei C,El Atiallah I,Colona VL,Mercuri NB,Bonsi P,Pisani A,Schirinzi T,Martella G

    更新日期:2020-05-01 00:00:00

  • Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis.

    abstract:INTRODUCTION:Pimavanserin is a selective 5-HT2A inverse agonist/antagonist approved for treating hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Results from short-term, placebo-controlled studies demonstrated a positive benefit/risk profile. This multi-year, open-label study assessed ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.06.026

    authors: Ballard CG,Kreitzman DL,Isaacson S,Liu IY,Norton JC,Demos G,Fernandez HH,Ilic TV,Azulay JP,Ferreira JJ,Abler V,Stankovic S,015 Study Group.

    更新日期:2020-08-01 00:00:00

  • Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease.

    abstract::The effectiveness of oral levodopa in complex Parkinson's disease (PD) is limited by its short half-life, and the resulting pulsatile dopaminergic stimulation leads to complex motor fluctuations and dyskinesia. Several treatments provide more continuous/less pulsatile dopaminergic stimulation by modifying the pharmaco...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2009.09.005

    authors: Clarke CE,Worth P,Grosset D,Stewart D

    更新日期:2009-12-01 00:00:00

  • Movement disorders in Latin America.

    abstract::The authors review some particularities of movement disorders (MDs) in the ethnically diverse population of Latin America. Although idiopathic diseases are evenly prevalent, access to treatment encounters difficulties that are worth discussing. Infectious-parasitic diseases observed throughout the continent occasional...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2005.08.009

    authors: Troiano AR,Micheli FE,Alarcón F,Teive HA

    更新日期:2006-04-01 00:00:00

  • Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.

    abstract:BACKGROUND:Nocturnal hypokinesia is a common symptom in Parkinson's disease (PD), negatively affecting quality of life of both patients and caregivers. However, evidence-based treatment strategies are limited. OBJECTIVE:To evaluate the efficacy of rotigotine transdermal patch, using a wearable sensor, in the managemen...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.parkreldis.2017.08.010

    authors: Bhidayasiri R,Sringean J,Chaiwong S,Anan C,Penkeaw N,Leaknok A,Boonpang K,Saksornchai K,Rattanachaisit W,Thanawattano C,Jagota P

    更新日期:2017-11-01 00:00:00